DMRA Damora Therapeutics, Inc.
Company Analysis
Latest News
🔴 Damora Therapeutics is trading 5% down
Damora Therapeutics is trading 5.18% lower at $17.77, with no company-specific announcement explaining the October 16, 2026 move surfaced in the available...
🔴 Damora Therapeutics is trading 5.6% down
Damora Therapeutics is trading 5.6% lower at $19.13 on October 13, 2026, with no clear company-specific announcement explaining the move. - The decline extends...
🟢 Damora Therapeutics is trading 5% up today with no specific catalyst identified
Damora Therapeutics is trading at $21.64, up 5.25%, alongside a broadly higher market, though no specific catalyst for the shares has been identified. - No...
🔴 Damora Therapeutics is trading 5% down on October 8, 2026 amid Riyadh explosions and an oil-price surge
Damora Therapeutics is trading at $19.22, down -5.04%, amid broader risk-off pressure following explosions in Riyadh and a sharp oil-price jump. - No clear...
🔴 Damora Therapeutics is trading 6.7% down; no clear catalyst identified
Damora Therapeutics is trading 6.7% lower at $18.86 on October 6, 2026, with no clear company-specific catalyst identified. - The latest company release found...
🔴 Damora Therapeutics is trading 5% down — catalyst remains unclear
Damora Therapeutics is trading 5.27% lower at $19.56, with no clear company-specific or broad-market catalyst identified for the October 5 decline. - The...
🟢 Damora Therapeutics is trading 6.5% up in pre-market after Guggenheim raised its price target to $60
Damora Therapeutics is trading 6.5% up at $22.00 before the September 28, 2026 open, with Guggenheim’s price-target increase a plausible company-specific...
Damora Therapeutics Target Rises to $60 on Guggenheim’s $3B mCALR Forecast
Guggenheim raised its price target for Damora Therapeutics to $60 from $40 and reiterated its Buy rating. The firm increased its global sales forecast for the...
🔴 Damora Therapeutics is trading 10.17% down today as oil and Treasury yields weigh on markets
Damora Therapeutics is trading 10.17% down at $20.13 on September 23, 2026, amid broad market weakness. - The Nasdaq Composite and S&P 500 are both down more...
🔴 Damora Therapeutics is trading 5.3% down today amid broader risk-off trading
Damora Therapeutics is trading at $21.23, down 5.29%, amid broader risk-off trading. - On September 23, 2026, the Nasdaq Composite was down 1.10% and the S&P...
🔴 Damora Therapeutics is trading 5.4% down today with no confirmed catalyst identified
Damora Therapeutics is trading 5.4% down at $23.21, with no confirmed catalyst identified. - No company-specific announcement dated September 17, 2026, was...
🔴 Damora Therapeutics is trading 10.11% down today as Treasury yields approached 5%
Damora Therapeutics is trading 10.11% down now at $25.52 amid broad market risk-off pressure. - Major U.S. indexes declined as Treasury yields approached 5%,...
🔴 Damora Therapeutics is trading 5.6% down today with no clear company-specific catalyst
Damora Therapeutics is trading 5.55% down at $26.82, but no clear company-specific announcement explains the September 15, 2026 decline. - The latest...
🟢 Damora Therapeutics is trading 5% up today as major indexes rise
Damora Therapeutics is trading 5.01% up now at $28.18 as of September 11, 2026, primarily aligned with broad risk-on sentiment as investors assessed August...
🟢 Damora Therapeutics is trading 5.5% up today
Damora Therapeutics is trading higher at $27.71, up +5.48%, despite no identified company-specific catalyst. - Its investor-relations page lists no...
🔴 Damora Therapeutics is trading 6.1% down today amid worsening insurance-coverage concerns
Damora Therapeutics is trading 6.1% down now at $27.39, with the move appearing primarily sector-driven as healthcare stocks face pressure amid worsening...
🟢 Damora Therapeutics is trading 6.27% up in pre-market
Damora Therapeutics is trading 6.27% up in pre-market at $31.00, versus the September 8 close of $29.17, with no major company-specific announcement dated...
🟢 Damora Therapeutics is trading 5.61% up today
Damora Therapeutics is trading 5.61% up at $29.57, with no clear company-specific catalyst identified for September 4, 2026. - The latest release announced...
🔴 Damora Therapeutics is trading 5% down today as higher oil prices pressure growth equities
Damora Therapeutics is trading 5.03% down at $27.54 amid a broader risk-off session, as higher oil prices, renewed U.S.-Iran tensions, elevated bond yields,...
🔴 Damora Therapeutics is trading 5.49% down today with no clear company-specific catalyst identified
Damora Therapeutics is trading 5.49% down at $28.92, with no clear company-specific announcement or catalyst identified for August 28, 2026. - Its...